Background & aims Irritable bowel syndrome (IBS) is one of the most common
gastrointestinal (GI) disorders, affecting about 10% of the general population globally. The …

Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly
reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for …

Background: Irritable bowel syndrome (IBS) is a complex syndrome that is difficult to
manage. Here we present the evidence supporting medication treatments for specific IBS …

A substantial proportion of patients with irritable bowel syndrome (IBS) associate their
symptoms with the ingestion of specific foods. Therefore, in recent years, scientific research …

Description Irritable bowel syndrome (IBS) is a commonly diagnosed gastrointestinal
disorder that can have a substantial impact on quality of life. Most patients with IBS associate …

New strategies for the care of irritable bowel syndrome (IBS) are developing and several
novel treatments have been globally produced. New methods of care should be customized …

Abstract Background The first British Dietetic Association (BDA) guidelines for the dietary
management of irritable bowel syndrome (IBS) in adults were published in 2012 …

Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction which can have
a considerable impact on quality of life. Following diagnosis, timely and evidence-based …

Background: IBS affects 5–11% of the population of most countries. Prevalence peaks in the
third and fourth decades, with a female predominance. Aim: To provide a guide for the …

INTRODUCTION Definition: IBS is a functional bowel disorder in which abdominal pain or
discomfort is associated with defecation and/or a change in bowel habit. Sensations of …